{"id":418177,"date":"2019-08-09T10:12:01","date_gmt":"2019-08-09T10:12:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=418177"},"modified":"2019-08-09T10:12:01","modified_gmt":"2019-08-09T10:12:01","slug":"hemodialysis-vascular-graft-market-size-to-be-valued-2765-million-by-2025-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hemodialysis-vascular-graft-market-size-to-be-valued-2765-million-by-2025-grand-view-research-inc_418177.html","title":{"rendered":"Hemodialysis Vascular Graft Market Size to be Valued $276.5 Million By 2025: Grand View Research, Inc"},"content":{"rendered":"
\"Hemodialysis<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The global hemodialysis vascular grafts market size was valued at USD 209.1 million in 2018. It is likely to expand at a CAGR of 4.1 % over the forecast period. <\/div>\n

The global Hemodialysis Vascular Grafts Market<\/a><\/strong> size is expected to reach USD 276.5 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.1% during the forecast period. Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.<\/p>\n

The global hemodialysis vascular graft market, by raw material, was dominated by PTFE grafts with a revenue share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High product penetration, wide availability, and comparatively cheaper products are supplementing the dominance of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its adoption, owing to lower possibility of rejection and infection of these products.<\/p>\n

North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of the market in the country can be attributed to growing number of renal impaired patients undergoing hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.<\/p>\n

Developing economies such as China and India have lower availability of kidney donors as compared to developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing awareness regarding safety of AVG, and rising healthcare expenditure.<\/p>\n

\"U.S.<\/strong><\/p>\n


Request a Sample Copy of the Global Hemodialysis Vascular Grafts Market Research Report @ https:\/\/www.grandviewresearch.com\/industry-analysis\/hemodialysis-vascular-grafts-market\/request\/rs1<\/a><\/strong><\/p>\n

Further Key Findings From the Report Suggest:<\/span><\/strong><\/p>\n